The latest research from Fore Pharma, Global Glioblastoma Market and Competitive Landscape – 2020, provides comprehensive insights into Glioblastoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Glioblastoma market size and drug sales. It also provides insights into Glioblastoma epidemiology and late stage pipeline.
This research covers the following – Glioblastoma treatment options, Glioblastoma late stage clinical trials pipeline, Glioblastoma prevalence by countries, Glioblastoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Glioblastoma pipeline: Find out drugs in clinical trials for Glioblastoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Glioblastoma epidemiology: Find out number of patients diagnosed (prevalence) with Glioblastoma by countries
– Glioblastoma drugs: Identify key drugs marketed and prescribed for Glioblastoma by countries, including trade name, molecule name, and company
– Glioblastoma drugs sales: Find out the sales value for Glioblastoma drugs by countries
– Glioblastoma market valuations: Find out the market size for Glioblastoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Glioblastoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Glioblastoma drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Glioblastoma market
– Develop in-depth knowledge of competition and markets
– Analyze Glioblastoma drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Glioblastoma market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Glioblastoma Treatment Options
2. Glioblastoma Pipeline Insights
2.1. Glioblastoma Phase 3 Clinical Trials
2.2. Glioblastoma Phase 2 Clinical Trials
2.3. Glioblastoma Phase 1 Clinical Trials
3. Glioblastoma Epidemiology Analysis by Countries
4. US Glioblastoma Market Insights
4.1. Marketed Drugs for Glioblastoma in US
4.2. US Glioblastoma Market Size & Forecast
4.3. US Glioblastoma Drugs Sales & Forecast
4.4. US Glioblastoma Market Share Analysis
5. Germany Glioblastoma Market Insights
5.1. Marketed Drugs for Glioblastoma in Germany
5.2. Germany Glioblastoma Market Size & Forecast
5.3. Germany Glioblastoma Drugs Sales Forecast
5.4. Germany Glioblastoma Market Share Analysis
6. France Glioblastoma Market Insights
6.1. Marketed Drugs for Glioblastoma in France
6.2. France Glioblastoma Market Size & Forecast
6.3. France Glioblastoma Product Sales Forecast
6.4. France Glioblastoma Market Share Analysis
7. Italy Glioblastoma Market Insights
7.1. Marketed Drugs for Glioblastoma in Italy
7.2. Italy Glioblastoma Market Size & Forecast
7.3. Italy Glioblastoma Product Sales Forecast
7.4. Italy Glioblastoma Market Share Analysis
8. Spain Glioblastoma Market Insights
8.1. Marketed Drugs for Glioblastoma in Spain
8.2. Spain Glioblastoma Market Size & Forecast
8.3. Spain Glioblastoma Product Sales Forecast
8.4. Spain Glioblastoma Market Share Analysis
9. UK Glioblastoma Market Insights
9.1. Marketed Drugs for Glioblastoma in UK
9.2. UK Glioblastoma Market Size & Forecast
9.3. UK Glioblastoma Product Sales Forecast
9.4. UK Glioblastoma Market Share Analysis
10. Europe Glioblastoma Market Insights
10.1. Europe Glioblastoma Market Size & Forecast
10.2. Europe Glioblastoma Product Sales Forecast
10.3. Europe Glioblastoma Market Share Analysis
11. Japan Glioblastoma Market Insights
11.1. Marketed Drugs for Glioblastoma in Japan
11.2. Japan Glioblastoma Market Size & Forecast
11.3. Japan Glioblastoma Product Sales Forecast
11.4. Japan Glioblastoma Market Share Analysis
12. Global Glioblastoma Market Insights
12.1. Global Glioblastoma Market Size & Forecast
12.2. Global Glioblastoma Product Sales Forecast
12.3. Global Glioblastoma Market Share Analysis
13. Research Methodology
List of Tables
1: Glioblastoma Phase 3 Clinical Trials, Global, 2020
2: Glioblastoma Phase 2 Clinical Trials, Global, 2020
3: Glioblastoma Phase 1 Clinical Trials, Global, 2020
4: Glioblastoma Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Glioblastoma in US, 2019
6: US Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
7: US Glioblastoma Product Sales ($mn), 2016 – 2025
8: US Glioblastoma Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Glioblastoma in Germany, 2019
10: Germany Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
11: Germany Glioblastoma Product Sales ($mn), 2016 – 2025
12: Germany Glioblastoma Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Glioblastoma in France, 2019
14: France Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
15: France Glioblastoma Product Sales ($mn), 2016 – 2025
16: France Glioblastoma Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Glioblastoma in Italy, 2019
18: Italy Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
19: Italy Glioblastoma Product Sales ($mn), 2016 – 2025
20: Italy Glioblastoma Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Glioblastoma in Spain, 2019
22: Spain Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
23: Spain Glioblastoma Product Sales ($mn), 2016 – 2025
24: Spain Glioblastoma Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Glioblastoma in UK, 2019
26: UK Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
27: UK Glioblastoma Product Sales ($mn), 2016 – 2025
28: UK Glioblastoma Market Events and Trends, 2016 – 2025
29: Europe Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
30: Europe Glioblastoma Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Glioblastoma in Japan, 2019
32: Japan Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
33: Japan Glioblastoma Product Sales ($mn), 2016 – 2025
34: Japan Glioblastoma Market Events and Trends, 2016 – 2025
35: Global Glioblastoma Market Size & Forecast ($mn), 2016 – 2025
36: Global Glioblastoma Product Sales ($mn), 2016 – 2025
List of Figures
1: Glioblastoma Pipeline by Phase (%), Global, 2020
2: Glioblastoma Prevalence by Countries, 2016 – 2025
3: US Glioblastoma Market Size ($mn), 2016 – 2025
4: US Glioblastoma Product Sales ($mn), 2016 – 2025
5: US Glioblastoma Market Share by Drugs (%), 2019
6: US Glioblastoma Market – Future Market Share (%), 2025
7: Germany Glioblastoma Market Size ($mn), 2016 – 2025
8: Germany Glioblastoma Product Sales ($mn), 2016 – 2025
9: Germany Glioblastoma Market Share by Drugs (%), 2019
10: Germany Glioblastoma Market – Future Market Share (%), 2025
11: France Glioblastoma Market Size ($mn), 2016 – 2025
12: France Glioblastoma Product Sales ($mn), 2016 – 2025
13: France Glioblastoma Market Share by Drugs (%), 2019
14: France Glioblastoma Market – Future Market Share (%), 2025
15: Italy Glioblastoma Market Size ($mn), 2016 – 2025
16: Italy Glioblastoma Product Sales ($mn), 2016 – 2025
17: Italy Glioblastoma Market Share by Drugs (%), 2019
18: Italy Glioblastoma Market – Future Market Share (%), 2025
19: Spain Glioblastoma Market Size ($mn), 2016 – 2025
20: Spain Glioblastoma Product Sales ($mn), 2016 – 2025
21: Spain Glioblastoma Market Share by Drugs (%), 2019
22: Spain Glioblastoma Market – Future Market Share (%), 2025
23: UK Glioblastoma Market Size ($mn), 2016 – 2025
24: UK Glioblastoma Product Sales ($mn), 2016 – 2025
25: UK Glioblastoma Market Share by Drugs (%), 2019
26: UK Glioblastoma Market – Future Market Share (%), 2025
27: Europe Glioblastoma Market Size ($mn), 2016 – 2025
28: Europe Glioblastoma Product Sales ($mn), 2016 – 2025
29: Europe Glioblastoma Market Share by Drugs (%), 2019
30: Europe Glioblastoma Market – Future Market Share (%), 2025
31: Japan Glioblastoma Market Size ($mn), 2016 – 2025
32: Japan Glioblastoma Product Sales ($mn), 2016 – 2025
33: Japan Glioblastoma Market Share by Drugs (%), 2019
34: Japan Glioblastoma Market – Future Market Share (%), 2025
35: Global Glioblastoma Market Size ($mn), 2016 – 2025
36: Global Glioblastoma Product Sales ($mn), 2016 – 2025
37: Global Glioblastoma Market Share by Drugs (%), 2019
38: Global Glioblastoma Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.